Clinical Trial Update: Individual Patient Esmethadone (REL-1017) Expanded Access Program

View source ↗

Summary

Expanded Access Program update for esmethadone (REL-1017) for major depressive disorder. The program is temporarily not available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Esmethadone (esmethadone)

Snippet

Sponsor: Relmada Therapeutics, Inc. | Conditions: Major Depressive Disorder, Depression | Status: TEMPORARILY_NOT_AVAILABLE